- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03333473
Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia (PPFP Choices)
The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private-for-profit sectors. The ultimate intent of this investment is to advance and scale up post-pregnancy FP. Programmatic learning will be crucial to understanding what it will take to accelerate post-pregnancy FP in these two countries, and these can later be adapted by other countries with similar settings. Our vision of PPFP Choices can be achieved through the following objectives:
- Objective 1: Establish a comprehensive program implementation framework for the private sector to embrace post-pregnancy FP
- Objective 2: Improve the quality of post-pregnancy FP counseling and service provision in both public and private sectors
- Objective 3: Build evidence and contribute to the literature and programmatic guidance around post-pregnancy FP uptake and continuation in both public and private sectors
- Objective 4: Ensure effective documentation and strategic dissemination which will benefit post-pregnancy FP introduction and scale-up more broadly
Study Overview
Status
Detailed Description
PPFP Choices is an operations research study seeking to examine the barriers and facilitators in offering a full range of FP methods in the immediate post-pregnancy period in both the public and private sectors.
Jhpiego will implement the study in two counties in Kenya; Meru and Kilifi, and two districts in Indonesia; Brebes and Batang.
This study will employ a quasi-experimental design with an intervention and control group. Prior to study start-up, the the intervention group will receive a Jhpiego-designed package of interventions designed to advance post-pregnancy FP in both the public and private sectors. These interventions draw on WHO's Programming Strategies for Postpartum Family Planning, as well as Jhpiego's experience and assessments. After the study is completed, the control groups will receive the same intervention. For the study, a mixed method approach will be used; both quantitative and qualitative data will be collected through Client Quantitative Interviews, Client In-Depth interviews, Focus Group Discussions, Key Informant Interviews, and Facility Assessments.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Central Java
-
Batang, Central Java, Indonesia, 51216
- RSU QOlbu Insan Mulia
-
Batang, Central Java, Indonesia, 51262
- Puskesmas Subah
-
-
Jawa Tengah
-
Batang, Jawa Tengah, Indonesia, 51215
- RSUD Batang
-
Batang, Jawa Tengah, Indonesia, 51274
- Puskesmas Bawang
-
Brebes, Jawa Tengah, Indonesia, 52212
- RSUD Brebes
-
Brebes, Jawa Tengah, Indonesia, 52255
- Puskesmas Kecipir
-
Brebes, Jawa Tengah, Indonesia, 52263
- Puskesmas Ketanggungan
-
Brebes, Jawa Tengah, Indonesia, 52273
- RSU Alam Medika Bumi Ayu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Kenyan postpartum participant (Enrollment starts at ANC):
- At least 28 weeks pregnant
- Plans to deliver at the study facility
- Aged 15-49 years at enrollment
- Provides voluntary informed consent
- Not planning to relocate in the next 12 months
Indonesian postpartum participant (Enrollment starts at L&D):
- In the immediate postpartum period (within 72 hours, prior to leaving the health facility),
- Reported having attended ANC within her 3rd trimester (28-weeks pregnant and later),
- Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
- Provides voluntary informed consent
- Not planning to relocate in the next 12 months
Kenyan and Indonesian postabortion participants:
- A female in the immediate post-pregnancy treatment phase (within 72 hours in Indonesia, within 48 hours in Kenya, prior to leaving the health facility for treatment of incomplete abortion)
- Aged 15-49 years at time of enrollment (Indonesian adolescents aged 15-16 must be married for purposes of the study consent)
- Provides voluntary informed consent
- Not planning to relocate in the next 6 months
Exclusion Criteria:
- Refusal to sign consent form for inclusion in the study
- Post-delivery baby or mother being treated for trauma or in an intensive care unit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The intervention will be applied to health facilities in one district in Indonesia and one county in Kenya.
The intervention package will work within existing public and private health facilities to strengthen and assess the effectiveness of facility and provider level PPFP service provision and counseling, and expand method choice for women during antenatal, early labor, and post-pregnancy pre-discharge periods.
Training within the intervention package include provider-lever PPFP counseling and service provision (PPFP Clinical and Counseling Skills), as well as provider and facility-level leadership management and governance training (Facility-Level Leadership Management and Governance Training).
|
Facilities will receive whole-site orientations on PPFP basics and skills Through training of trainers, followed by classroom and model-based and clinical-based practice, providers will receive training in PPDP counseling and service provision.
The intervention will strengthen leadership management and governance practices required to help managers establish PPFP services at the facility level.
|
|
No Intervention: Control
The health facilities control district in Indonesia and county in Kenya will continue with their standard counseling and service provision throughout the study period.
At the conclusion of the study period, the facilities in these areas will receive the same intervention that Intervention facilities received prior to study startup.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of PPFP counseling
Time Frame: 3 years
|
80% of ANC attendees and women receiving postabortion care receive appropriate PPFP counseling prior to discharge compared to baseline in the comparison group.
|
3 years
|
|
Clinical competency of service providers in providing all modern FP methods
Time Frame: 3 years
|
100% of service providers in intervention arm of study are deemed competent and retain competencies to provide all modern FP methods to women during postpartum and postabortion periods.
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum uptake of LARCs
Time Frame: 3 years
|
50% increase in Long-Acting and Permanent Method use by study participants whose infants are six months old in study intervention sites in Indonesia and 70% increase in LARC use by study participants whose infants are six months old in study intervention sites in Kenya.
A change in use of LARCs and other permanent methods of FP by study participants whose infants are six months old, from 10% to 15% in Indonesia and from 6% to 10% in Kenya at intervention facilities over the course of the study
|
3 years
|
|
Health facility-level leadership management and governance skills
Time Frame: 3 years
|
80% of health facilities in the intervention group show improvement in leadership management and government measured through use of quality improvement approaches
|
3 years
|
|
Assessment of individual intervention quality
Time Frame: 3 years
|
Using a quality improvement framework, assess individual pieces of the intervention package using multi-level modeling
|
3 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elaine Charurat, MBA, MHS, Jhpiego
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00007462
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The study protocol will be shared through publication in a peer-reviewed journal.
De-identified participant data will be submitted to a data repository in accordance with the Bill and Melinda Gates Foundation and Merck for Mothers policies.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-pregnancy Family Planning
-
Marie Stopes InternationalLondon School of Hygiene and Tropical MedicineCompletedContraception | mHealth | Post-abortion Family PlanningCambodia
-
Boston CollegeEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingUnintended Pregnancy | Family PlanningUganda
-
Washington University School of MedicineCenters for Medicare and Medicaid ServicesCompletedContraception | Unintended Pregnancy | Family PlanningUnited States
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedFeasibility | Unintended Pregnancy | Family Planning | AcceptabilityIndia
-
Oregon Health and Science UniversityUniversity of Colorado, Denver; Public Health - Seattle and King County; Clark... and other collaboratorsCompletedPregnancy | Family Planning | Effective Contraceptive UseUnited States
-
University of California, San DiegoBill and Melinda Gates Foundation; Population Council; International Planned...CompletedUnintended Pregnancy | Family Planning | Intimate Partner Violence (IPV)United States
-
University of California, San DiegoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUnintended Pregnancy | Family Planning | Intimate Partner Violence (IPV)United States, Mexico
-
Assiut UniversityNot yet recruiting
-
RANDMakerere UniversityNot yet recruitingFamily Planning
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
Clinical Trials on PPFP Clinical and Counseling Skills
-
JhpiegoUnited States Agency for International Development (USAID); Bill and Melinda...CompletedPregnancy | Contraception | Contraceptive Usage | Prenatal Care | Postpartum Family PlanningEthiopia
-
University of ConnecticutMedical Research Council, South AfricaActive, not recruitingHIV I InfectionUnited States
-
Instituto Mexicano del Seguro SocialCompletedCOVID-19 Pandemic | Educational Problems | Medical StudentsMexico
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH); Rutgers UniversityCompleted
-
Mashhad University of Medical SciencesCompletedNursing Student
-
University of PittsburghWest Penn Allegheny Health SystemCompletedSystemic Lupus ErythematosusUnited States
-
University of South FloridaUnknown
-
University of Colorado, DenverAmerican Institute for Cancer ResearchRecruiting
-
Institut National de la Santé Et de la Recherche...Completed
-
Izmir Katip Celebi UniversityMarmara UniversityActive, not recruitingPregnancy | Sexual Dysfunction | Postpartum Period | PLISSIT Model | Sexual CounsellingTurkey